Dongguan Trial Medical Co., Ltd. stands as a titan in the domain of remote clinical trial monitoring and decentralized clinical trial (DCT) technologies. Since our inception in 2016, we have transitioned from a specialized hardware manufacturer to a holistic provider of AI-Powered Clinical Assessment Tools. Our mission is to bridge the gap between patient safety and data integrity through the implementation of advanced neural networks and high-fidelity IoT sensors.
Modern clinical research faces a dual challenge: the need for patient-centricity (reducing site visits) and the uncompromising demand for Real-World Evidence (RWE). Our suite of AI-enhanced tools addresses these by offering automated electronic Clinical Outcome Assessments (eCOA), smart wearable integration, and predictive safety analytics. Located in the heart of China’s advanced manufacturing hub, Dongguan, we leverage a 11,000sqm facility and 230+ specialists to redefine what "Made in China" means for the global pharmaceutical sector.
Reducing patient burden by bringing the trial to their homes. Our tools enable hybrid and virtual models with 99.9% data sync uptime.
Integrating machine learning algorithms into ophthalmic and hematological analyzers to provide clinicians with real-time decision support.
Utilizing remote monitoring to detect adverse events (AEs) before they escalate, using AI-driven anomaly detection on vital sign data.
Our technical trajectory is focused on Multimodal Data Fusion. By 2025, Trial Medical aims to integrate Large Language Models (LLMs) into our patient engagement platforms to automate the coding of patient-reported outcomes (ePRO), significantly reducing the administrative load on clinical coordinators.
The "Information Gain" we provide to sponsors is not just hardware; it is the accuracy of the digital signal. Our AI-powered sensors filter out noise (movement artifacts) in wearable data, ensuring that the "Active Minutes" or "Resting Heart Rate" reported in a trial are clinically valid and statistically significant.
Our Dongguan facility is an embodiment of Supply Chain 4.0. By localizing the entire lifecycle—from PCB assembly to software validation—we offer unmatched agility for OEM/ODM requirements. This vertical integration ensures that global pharmaceutical companies can pivot their trial hardware needs within weeks, rather than months.
Utilization of air-bearing technology for heavy-duty medical manufacturing platforms, ensuring sub-micron accuracy in device assembly.
Real-time batch tracking and pallet-level data capture systems to prevent counterfeiting and ensure end-to-end supply chain visibility.
Automated optical inspection (AOI) and plasma disinfection processes that meet international hospital-grade sterilization standards.
Trust is the cornerstone of clinical trials. Trial Medical provides comprehensive support for international regulatory landscapes:
Regulatory Certifications: We maintain a rigorous quality management system (QMS) compliant with ISO 13485. Our products are designed to meet the stringent requirements of the FDA (USA), EMA (Europe), and NMPA (China).
Data Privacy: AI-powered data anonymization ensures that all transmitted clinical data adheres to GDPR and HIPAA standards, protecting patient identity while maximizing research utility.
